Insights

Minneapolis – June 30, 2026: Crowell & Moring has added experienced antitrust senior counsel Ryan Marth to the Antitrust and Competition Group in Minneapolis. Marth will advise clients on complex antitrust litigation, opt-out plaintiff recovery, and cross-border transactional and regulatory matters. 

Washington – June 4, 2026: Crowell & Moring earned 92 individual rankings for 81 attorneys, as well as 48 national and statewide practice area rankings, in the Chambers USA 2026 guide. The Chambers guide ranks the country’s top law firms and lawyers through in-depth research, client interviews, and feedback from attorneys at peer firms. 

Washington – May 13, 2026: Crowell & Moring has opened a new office in Minneapolis, Minnesota, with a focus on the firm’s regulatory, enforcement and litigation strengths in areas including health care, antitrust and competition, and labor and employment. The office launches with an initial team of eight attorneys, including partners Toni Michelle Jackson and Jeff Gleason, with additional growth anticipated in the near term. Minneapolis is Crowell’s 13th office and follows office openings last year in Boston and Dallas.

A recent enforcement action led by Minnesota Attorney General Keith Ellison along with a bipartisan coalition of state attorneys general signals an accelerating and coordinated crackdown on competitively sensitive information-sharing arrangements.

In June 2026, federal regulators and lawmakers continued their efforts to improve drug affordability through targeted reforms. These recent developments will primarily impact pharmaceutical manufacturers, managed care organizations, and pharmacy benefit managers (PBM) serving Medicare Part D program members. PBMs, Medicare Advantage organizations, and Part D sponsors should monitor these changes in the interest of maintaining compliance and providing input on regulatory proposals that may influence their business operations or compensation structures in the future.

When the U.S. Court of Appeals for the Fifth Circuit vacated the FTC's Combating Auto Retail Scams (CARS) Rule in January 2025 on procedural grounds, some dealers may have interpreted the decision as a signal that federal regulatory pressure on the auto industry had eased. Recent developments make clear that such optimism was misplaced.